Canada markets open in 1 hour 28 minutes

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3831-0.0030 (-0.77%)
At close: 3:58PM EDT
Sign in to post a message.
  • B
    Bernard
    Been reading reviews on reddit for the 20/1 strain Khiron is shipping to Germany, seems like people in the UK are loving it and switching out competitors products for the Khiron product. Nimbus is ordering 3x more then last time as I understand it, if it sells out quickly I'm pretty sure they will order 3x more (Around 100kg) next time.
  • S
    Sachin
    Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients
  • R
    Richard
  • P
    Philip
    Any educated guesses why the SP is not moving AT ALL with all the bullish news and positive outlook with Khiron? What more
    Proof do investors need?

    And please don’t say their small war chest
  • M
    Martin
    great news again with largest shipping to EU. q2 will be a lot better than q1
  • M
    MoonShot
    Alvarro mentioned on the Benzinga conference today that the Peru clinic opened up yesterday?
  • M
    Martin
    just listened in to the webcast...I'm liking what I'm hearing and don't think cash in hand will be an issue moving forward as clinics and revenues continue to ramp up and set records q over q moving forward..some expenses will continue to go down but some remain and will get offset by money brought in...price drop=buy more for me! glta
  • P
    Philip
    Report looks great, cash burn only negative but will hear more tomorrow. Assuming it’s for rapid expansion which was already mentioned. Last CC Alvaro stated no need for any solution short term and no need for partnership as their niche in LATAM working well.

    All signs point to positivity and rapid growth. First mover and shaker in LATAM and in my opinion only blue skies from here
  • E
    Ernest
    On the bright side...Khirion growing...Aurora and Canopy going backwards... if only management would stop putting themselves and their interest over shareholders.
  • S
    Sachin
    ATB Capital Maintain Speculative Buy with an Unchanged Price Target of $1.00: Our price target is based on our DCF projected through 2030e using a 17% discount rate and a 3% terminal growth rate, both unchanged. The terminal value accounts for 39% of our fair value estimate. Our rating reflects the regulatory uncertainty for cannabis use across LATAM.”
  • M
    Martin
    another positive..the Qs should keep trending positive with 44% of total prescriptions of q4 2020 already filled by April..q2 should be even better with Peru opening up another clinic in the coming weeks and other regions like UK and Germany ramping up
  • J
    Jason
    I see no way to expand into Mexico without another share offering to raise funds to push that initiative forward.
  • c
    ctbarb1
    Not worried at all. Khiron held up well during the last year with fiscal management compared to a lot of peers. I picked up another 19,000 shares and would buy more if I wasn't already buying other sales right now.
  • J
    Jonn
    Company recorded a net loss of $5.5 million in Q1 2021,
  • P
    Pric
    SAVE THE DATE!

    Khiron invites individual and institutional investors, as well as advisors and analysts, to attend a Q1/2021 Earnings call.

    DATE: May 28th, 2021

    TIME: 10:00am ET/7:00am PT

    PRESENTERS: Alvaro Torres, Khiron Chief Executive Officer and Director, Joel Friedman, Khiron Chief Financial Officer, and Chris Naprawa, Chairman of Khiron Board of Directors

    FORMAT: Live 30 minutes presentation & Q&A session

    REGISTER LINK: https://event.on24.com/wcc/r/3196006/0652A31C731C234FE0C2F998FCEBFFEB

    Please submit any questions you may have in advance to investors@khiron.ca and we will do our best to address them during the webinar.
  • S
    Sachin
    Khiron Partners with Colombia Cancer League to Deliver 3,000 Medical Cannabis Patient Consultations
  • M
    Mark
    Friday should be a big day for this company ... looking forward to some positive revenue momentum!